Segar Kumala Indonesia Tbk vs Cipta Sarana Medika Tbk. — how do they compare? Segar Kumala Indonesia Tbk trades at Rp520 (market cap 1.04T, 253.7K 24h volume), while Cipta Sarana Medika Tbk. trades at Rp63 (market cap 158.12B, 8.21M 24h volume). The key difference: Segar Kumala Indonesia Tbk is far larger — about 6.6× Cipta Sarana Medika Tbk.'s market cap, and Cipta Sarana Medika Tbk. is more actively traded (8.21M versus 253.7K). Which is the better fit depends on your goals.
| BUAH | DKHH | |
|---|---|---|
Market Cap | 1.04T | 158.12B |
Volume | 253.7K | 8.21M |
Lot | 2.54K | 82.15K |
Turnover | 130.28M | 515.2M |
Average Price | 513.52 | 62.72 |
Value | 130.28M | 515.2M |
Indicative Equilibrium Price | 520 | 63 |
Indicative Equilibrium Volume | 430 | 1.33K |
Trailing returns across standard periods
Latest headlines on both assets
PT Segar Kumala Indonesia Tbk (“the Company”) was established based on Notarial Deed of P. Sutrisno A. Tampubolon, No. 14 dated June 10, 2017.
Read more on BUAH →PT Cipta Sarana Medika Tbk (the Company) was established based on Deed No. 90 dated September 17, 2014 by Dede Fujianti, SH., M.Kn., Notary in Sukabumi. The Company ultimate parent entity is PT Siliwangi Djajakusumah Bersatu. The Company started its commercial operations in 2014.
Read more on DKHH →